FDA Approval: ARGATROBAN IN 0.9% SODIUM CHLORIDE (ARGATROBAN) — Type 5 - New Formulation or New Manufacturer
Hematology
Government source· FDAverify ↗HCPCS Level II code
—
No national Medicare fee schedule we hold prices J0883 — the Physician Fee Schedule lists it with status indicator E (2026 file). CMS fee schedules ↗
Code definition
Code
J0883
Code system
HCPCS Level II
Full description
Injection, argatroban, 1 mg (for non-esrd use)
CLV Intelligence is tracking 3 policy changes that cite HCPCS J0883 between 2026-07-01 and 2026-08-06, drawn from 3 FDA notices. The changes span Hematology.
Counts reflect the source documents CLV has matched to HCPCS J0883 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to J0883
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Hematology
Government source· FDAverify ↗+ 1 more alert — subscribe to view
Search J0883 across all alerts
Full history of CMS and MAC policy changes matched to this code.
Audit documentation
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get alerts when policy changes affect J0883
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy